Clinical Feature, Lifestyle Behavior and Non-Communicable Diseases Comorbidities Among Psoriasis Patients in Shanghai: Gender Disparity Analysis Based on a Cross-Sectional Study

Background Gender difference is prevalent in clinical feature, disease severity for noncommunicable diseases (NCD), but studies on gender disparity in clinical feature, disease severity and NCD comorbidity among psoriasis patients are limited. This cross-sectional study explores gender differences in clinical feature, lifestyle behavior and NCD comorbidity among psoriasis patients. Methods Psoriasis patients were recruited through cluster survey method in two hospitals, and questionnaire interviews were applied to collect the demographic feature, lifestyle habits, clinical feature and NCD among patients. Results A total of 2102 psoriasis patients included 1332 males (63.4%), 70% were over 35 years old and approximately 50% of them were overweight or obesity. The median value for psoriasis initiation age and disease duration was 33 years old (34 for male and 32 for female) and 9 years (10 for male and 7 for female), respectively. The psoriasis recurrence was mainly in winter (73.4%) and autumn (34.2%) both for patients. The prevalence of tobacco smoking and alcohol drinking was 31.2% and 12.6%. Male patients had higher prevalence of tobacco smoking (odds ratio (OR) = 13.26, 95% confidence interval (CI): 9.54–18.44) and alcohol drinking (OR = 14.44, 95% CI: 7.90–26.40). The prevalence of diabetes, hypertension, hyperlipidemia, and metabolic syndrome were 13.2%, 28.5%, 23.4% and 21.5%, respectively. Male patients had higher prevalence of diabetes (OR = 1.53, 95% CI: 1.16–2.02), hypertension (OR = 1.87, 95% CI: 1.52–2.30), hyperlipidemia (OR = 2.34, 95% CI: 1.85–2.95) and metabolic syndrome (OR = 2.06, 95% CI: 1.63–2.62) than female patients. The proportions for 4 types of NCDs diagnosed after psoriasis onset were over 58%, which were also higher in males than females. Conclusion Female patients had shorter disease duration and with less NCD, and male patients had more body weight issue, with fewer sleep time and higher prevalence of tobacco smoking and alcohol drinking and NCDs. We recommend that dermatologist should notice the gender disparity in psoriasis patients, which is helpful for the disease diagnosis and treatment.

[1]  L. Rudnicka,et al.  Chronic Plaque Psoriasis in Poland: Disease Severity, Prevalence of Comorbidities, and Quality of Life , 2022, Journal of clinical medicine.

[2]  Rui Zhang,et al.  Tobacco smoking was positively associated with metabolic syndrome among patients with psoriasis in Shanghai: A cross-sectional study , 2022, Tobacco induced diseases.

[3]  I. Flisiak,et al.  Assessment of Life Quality, Stress and Physical Activity Among Patients with Psoriasis , 2021, Dermatology and Therapy.

[4]  Esed Omerkić,et al.  Comorbidity in Men with Psoriasis , 2021, Medical archives.

[5]  A. Stănescu,et al.  Oral Vitamin D Therapy in Patients with Psoriasis , 2021, Nutrients.

[6]  G. Fischer,et al.  Use of narrowband ultraviolet B (NBUVB) in paediatric psoriasis: A systematic literature review and meta‐analysis , 2020, The Australasian journal of dermatology.

[7]  A. Maggioni,et al.  [Sex and gender medicine: the foundation of gender medicine]. , 2020, Giornale italiano di cardiologia.

[8]  C. Griffiths,et al.  Diurnal and seasonal variation in psoriasis symptoms , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  D. Solmaz,et al.  The impact of smoking on prevalence of psoriasis and psoriatic arthritis. , 2020, Rheumatology.

[10]  S. Donell,et al.  Gender medicine: its historical roots , 2020, Postgraduate Medical Journal.

[11]  A. Armstrong,et al.  Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. , 2020, JAMA.

[12]  I. Iskandar,et al.  Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender * , 2020, The British journal of dermatology.

[13]  Juan Su,et al.  Prevalence and risk factors of atopic dermatitis, psoriasis, acne, and urticaria in China. , 2020, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[14]  A. Navarini,et al.  Gender differences in psoriasis: a Swiss online psoriasis survey , 2020, Archives of Dermatological Research.

[15]  M. Napolitano,et al.  Sex‐ and gender‐associated clinical and psychosocial characteristics of patients with psoriasis , 2020, Clinical and experimental dermatology.

[16]  M. Simpson,et al.  Psoriasis and Genetics , 2020, Acta dermato-venereologica.

[17]  T. Tsai,et al.  Psoriasis and Co-morbidity , 2020, Acta dermato-venereologica.

[18]  K. Blomquist,et al.  A longitudinal study of weight and shape concerns and disordered eating groups by gender and their relationship to self-control , 2020, Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.

[19]  H. Pan,et al.  Seasonality and global public interest in psoriasis: an infodemiology study , 2019, Postgraduate Medical Journal.

[20]  Yu-Huei Huang,et al.  Familial Aggregation of Psoriasis and Co-Aggregation of Autoimmune Diseases in Affected Families , 2019, Journal of clinical medicine.

[21]  Michael P. Lee,et al.  Psoriasis risk factors and triggers. , 2018, Cutis.

[22]  M. Andrews,et al.  Psoriasis and infection. A clinical practice narrative , 2018, The Australasian journal of dermatology.

[23]  A. Alexis,et al.  Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups , 2018, American Journal of Clinical Dermatology.

[24]  L. Naldi,et al.  The global state of psoriasis disease epidemiology: a workshop report , 2017, The British journal of dermatology.

[25]  S. Langan,et al.  Psoriasis and comorbid diseases: Epidemiology. , 2017, Journal of the American Academy of Dermatology.

[26]  S. John,et al.  A systematic review of worldwide epidemiology of psoriasis , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[27]  L. Naldi.  Psoriasis and smoking: links and risks , 2016, Psoriasis.

[28]  L. Misery,et al.  Alcohol consumption and psoriasis: a systematic literature review , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[29]  Y. Ko,et al.  Psoriasis as initiator or amplifier of the systemic inflammatory march: impact on development of severe vascular events and implications for treatment strategy , 2013, Journal of the European Academy of Dermatology and Venereology.

[30]  A. Armstrong,et al.  Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. , 2013, Journal of the American Academy of Dermatology.

[31]  A. Armstrong,et al.  Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms , 2011, The British journal of dermatology.

[32]  W. Boehncke,et al.  The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity , 2011, Experimental dermatology.

[33]  A. Qureshi,et al.  Alcohol intake and risk of incident psoriasis in US women: a prospective study. , 2010, Archives of dermatology.

[34]  C. Griffiths,et al.  Pathogenesis and clinical features of psoriasis , 2007, The Lancet.

[35]  Tie-liu Shi,et al.  Association between alcohol, smoking and HLA-DQA1*0201 genotype in psoriasis. , 2004, Acta biochimica et biophysica Sinica.

[36]  Mark Lebwohl,et al.  Psoriasis , 1906, The Lancet.

[37]  P. Gisondi,et al.  Psoriasis and the metabolic syndrome. , 2018, Clinics in dermatology.

[38]  B. Lindegård.  Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. , 1986, Dermatologica.